Literature DB >> 8080372

Pilonidal sinus disease. The conservative approach.

J H Armstrong1, P J Barcia.   

Abstract

OBJECTIVE: To examine the role of conservative, nonexcisional methods in the treatment of pilonidal sinus disease.
DESIGN: Pilot nonrandomized cohort study and follow-up retrospective study. SETTING AND PATIENTS: In the pilot study, all patients treated for pilonidal sinus disease consecutively over 3 years at an Army community hospital, and in the follow-up study within a closed federal population, all patients admitted with a diagnosis of pilonidal sinus disease over 17 years to an Army medical center.
INTERVENTIONS: Conservative, nonexcisional therapy (meticulous hair control by natal cleft shaving, improved perineal hygiene, and limited lateral incision and drainage for abscess) with initial comparison to excisional procedures. MAIN OUTCOME MEASURES: Occupied-bed days for conservative vs excisional therapy during a 3-year pilot study and the number of admissions and procedures performed for pilonidal sinus disease at an institution dedicated to conservative treatment alone.
RESULTS: Complete healing over 83 occupied-bed days was demonstrated in 101 consecutive cases managed during 1 year with the conservative method, whereas slower healing over 4760 occupied-bed days was observed in 229 patients undergoing 240 operative procedures during the preceding 2 years. With application of conservative treatment over 17 years, only 23 excisional operations were performed.
CONCLUSIONS: Conservative therapy effectively controls pilonidal sinus disease in the nonoperative outpatient setting while promoting near-normal work status and is preferred over excisional operations.

Entities:  

Mesh:

Year:  1994        PMID: 8080372     DOI: 10.1001/archsurg.1994.01420330028006

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  37 in total

1.  Development of an evidence-based protocol for care of pilonidal sinus wounds healing by secondary intent using a modified Reactive Delphi procedure. Part 2: methodology, analysis and results.

Authors:  Connie L Harris; Samantha Holloway
Journal:  Int Wound J       Date:  2012-02-02       Impact factor: 3.315

2.  Pilonidal disease.

Authors:  Amit Khanna; John L Rombeau
Journal:  Clin Colon Rectal Surg       Date:  2011-03

Review 3.  Development of an evidence-based protocol for care of pilonidal sinus wounds healing by secondary intent using a modified reactive Delphi procedure. Part one: the literature review*.

Authors:  Connie L Harris; Samantha Holloway
Journal:  Int Wound J       Date:  2011-10-17       Impact factor: 3.315

4.  The treatment of pilonidal disease: guidelines of the Italian Society of Colorectal Surgery (SICCR).

Authors:  D Segre; M Pozzo; R Perinotti; B Roche
Journal:  Tech Coloproctol       Date:  2015-09-16       Impact factor: 3.781

5.  Author's reply to the letter of Doll et al.

Authors:  D Segre; M Pozzo; R Perinotti; B Roche
Journal:  Tech Coloproctol       Date:  2016-02-05       Impact factor: 3.781

Review 6.  Review of phenol treatment in sacrococcygeal pilonidal disease.

Authors:  Cuneyt Kayaalp; Cemalettin Aydin
Journal:  Tech Coloproctol       Date:  2009-08-05       Impact factor: 3.781

7.  Surgical treatment of pilonidal disease.

Authors:  John Bascom
Journal:  BMJ       Date:  2008-04-07

8.  The use of fibrin glue without surgery in the treatment of pilonidal sinus disease.

Authors:  Arda Isik; Ramazan Eryılmaz; Ismail Okan; Fatih Dasiran; Deniz Firat; Oguz Idiz; Mustafa Sahin
Journal:  Int J Clin Exp Med       Date:  2014-04-15

9.  Comparison of Karydakis flap reconstruction versus primary midline closure in sacrococcygeal pilonidal disease: results of 200 military service members.

Authors:  Mehmet Fatih Can; Mert Mahsuni Sevinc; Mehmet Yilmaz
Journal:  Surg Today       Date:  2009-06-28       Impact factor: 2.549

10.  Treating Pilonidal Disease: You Do Not Need to Detonate a Naval Mine to Catch a Fish.

Authors:  Moshe Schein
Journal:  World J Surg       Date:  2017-05       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.